Medical - Diagnostics & Research
Compare Stocks
2 / 10Stock Comparison
CHEK vs AEYE
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
CHEK vs AEYE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Diagnostics & Research | Software - Application |
| Market Cap | $12M | $95M |
| Revenue (TTM) | $0.00 | $40M |
| Net Income (TTM) | $-25M | $-3M |
| Gross Margin | — | 78.3% |
| Operating Margin | — | -7.9% |
| Total Debt | $136K | $721K |
| Cash & Equiv. | — | $5M |
CHEK vs AEYE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Jan 26 | Return |
|---|---|---|---|
| Check-Cap Ltd. (CHEK) | 100 | 19.8 | -80.2% |
| AudioEye, Inc. (AEYE) | 100 | 117.9 | +17.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHEK vs AEYE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHEK carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 0.67
- Lower volatility, beta 0.67, current ratio 0.15x
- Beta 0.67, current ratio 0.15x
AEYE is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 14.5%, EPS growth 30.6%, 3Y rev CAGR 10.5%
- 80.2% 10Y total return vs CHEK's -99.7%
- 14.5% revenue growth vs CHEK's -48.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.5% revenue growth vs CHEK's -48.5% | |
| Quality / Margins | 212.2% margin vs AEYE's -7.6% | |
| Stability / Safety | Beta 0.67 vs AEYE's 2.29 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +101.9% vs AEYE's -35.7% | |
| Efficiency (ROA) | -9.5% ROA vs CHEK's -66.7%, ROIC -42.4% vs -287.7% |
CHEK vs AEYE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CHEK vs AEYE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AEYE leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
AEYE and CHEK operate at a comparable scale, with $40M and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $0 | $40M |
| EBITDAEarnings before interest/tax | -$26M | -$504,000 |
| Net IncomeAfter-tax profit | -$25M | -$3M |
| Free Cash FlowCash after capex | -$8,004 | $2M |
| Gross MarginGross profit ÷ Revenue | — | +78.3% |
| Operating MarginEBIT ÷ Revenue | — | -7.9% |
| Net MarginNet income ÷ Revenue | — | -7.6% |
| FCF MarginFCF ÷ Revenue | — | +5.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +7.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -155.6% | +29.0% |
Valuation Metrics
AEYE leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $12M | $95M |
| Enterprise ValueMkt cap + debt − cash | $12M | $91M |
| Trailing P/EPrice ÷ TTM EPS | -0.48x | -30.64x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 2.36x |
| Price / BookPrice ÷ Book value/share | — | 19.80x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
AEYE leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
AEYE delivers a -47.8% return on equity — every $100 of shareholder capital generates $-48 in annual profit, vs $-2 for CHEK. On the Piotroski fundamental quality scale (0–9), AEYE scores 4/9 vs CHEK's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -2.3% | -47.8% |
| ROA (TTM)Return on assets | -66.7% | -9.5% |
| ROICReturn on invested capital | -2.9% | -42.4% |
| ROCEReturn on capital employed | -2.3% | -17.7% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | — | 0.15x |
| Net DebtTotal debt minus cash | $136,000 | -$5M |
| Cash & Equiv.Liquid assets | — | $5M |
| Total DebtShort + long-term debt | $136,000 | $721,000 |
| Interest CoverageEBIT ÷ Interest expense | -2883.22x | -2.79x |
Total Returns (Dividends Reinvested)
CHEK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEYE five years ago would be worth $3,632 today (with dividends reinvested), compared to $707 for CHEK. Over the past 12 months, CHEK leads with a +101.9% total return vs AEYE's -35.7%. The 3-year compound annual growth rate (CAGR) favors CHEK at 14.1% vs AEYE's 4.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +21.3% | -23.0% |
| 1-Year ReturnPast 12 months | +101.9% | -35.7% |
| 3-Year ReturnCumulative with dividends | +48.6% | +14.2% |
| 5-Year ReturnCumulative with dividends | -92.9% | -63.7% |
| 10-Year ReturnCumulative with dividends | -99.7% | +80.2% |
| CAGR (3Y)Annualised 3-year return | +14.1% | +4.5% |
Risk & Volatility
CHEK leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CHEK is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than AEYE's 2.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHEK currently trades 53.1% from its 52-week high vs AEYE's 46.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 2.29x |
| 52-Week HighHighest price in past year | $3.92 | $16.39 |
| 52-Week LowLowest price in past year | $0.59 | $5.31 |
| % of 52W HighCurrent price vs 52-week peak | +53.1% | +46.7% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 59.7 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 194K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
AEYE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CHEK leads in 2 (Total Returns, Risk & Volatility).
CHEK vs AEYE: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — CHEK or AEYE?
Over the past 5 years, AudioEye, Inc.
(AEYE) delivered a total return of -63. 7%, compared to -92. 9% for Check-Cap Ltd. (CHEK). Over 10 years, the gap is even starker: AEYE returned +80. 2% versus CHEK's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — CHEK or AEYE?
By beta (market sensitivity over 5 years), Check-Cap Ltd.
(CHEK) is the lower-risk stock at 0. 67β versus AudioEye, Inc. 's 2. 29β — meaning AEYE is approximately 241% more volatile than CHEK relative to the S&P 500.
03Which is growing faster — CHEK or AEYE?
On earnings-per-share growth, the picture is similar: AudioEye, Inc.
grew EPS 30. 6% year-over-year, compared to -43. 3% for Check-Cap Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — CHEK or AEYE?
Check-Cap Ltd.
(CHEK) is the more profitable company, earning 0. 0% net margin versus -7. 6% for AudioEye, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CHEK leads at 0. 0% versus -7. 9% for AEYE. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — CHEK or AEYE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is CHEK or AEYE better for a retirement portfolio?
For long-horizon retirement investors, Check-Cap Ltd.
(CHEK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67)). AudioEye, Inc. (AEYE) carries a higher beta of 2. 29 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CHEK: -99. 7%, AEYE: +80. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between CHEK and AEYE?
These companies operate in different sectors (CHEK (Healthcare) and AEYE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.